News about Biotechnology, Pharmaceutical and Healthcare

14:13 EDT 25th October 2014 | BioPortfolio

Latest news articles in the life-science, healthcare, medical device, biotechnology and pharmaceuticals sectors. 

Showing News Articles 1–25 of 9,300+

Saturday 25th October 2014

Universities receive share of £150m fund

The universities of Manchester, Leeds and Liverpool have secured a share of a £150m government investment in the UK's clinical research infrastructure. The University of Manchester has secured £12.8m while £5m has been awarded to ...

Friday 24th October 2014

Texas nurse free of Ebola virus; discharged from NIH Clinical Center

NIH Clinical Center discharges Nina Pham who is free of Ebola virus disease.

ACCIÓ is organizing trade mission to Japan and South Korea

The deadline to register is 7 November

Middle East respiratory syndrome coronavirus (MERS-CoV) – Turkey

On 17 October 2014, WHO EURO was notified by the National IHR Focal Point for Turkey of a laboratory-confirmed case of infection with Middle East respiratory syndrome coronavirus (MERS-CoV). On 11 October 2014, the patient died. This is the first MERS-CoV case in Turkey. Details of the case are as follows:

NIH media briefing on discharge of Ebola patient from its Clinical Center Special Clinical Studies Unit

NIH officials will brief reporters about the discharge of Nina Pham.

Extrapolation for biosimilars

Regarding extrapolation* of indications for biosimilars, the European Medicines Agency (EMA) has stated that ‘if clinical similarity can be shown in a key indication, extrapolation of efficacy and safety data to other indication(s) of the reference...

nLife Therapeutics Receives USD 350,000 from The Michael J. Fox Foundation for Parkinson’s Research

The funding will help characterize the mechanism of action of nLife’s lead compound NLF-PD-1233 in a Parkinson disease model and find a proper dose to engage clinical development. nLife Therapeutics, an early-stage biopharmaceutical company leading developments in nOligos (neuronal specific oligonucleotides) as therapeutic agents for CNS disorders, today announces that The Michael J. Fox Fou...

Biosimilar bevacizumab similar to Avastin in preclinical assessments

Preclinical assessments have demonstrated the similarity of biologicals major Amgen’s biosimilar bevacizumab candidate (ABP 215) to Avastin [1].

WHO convenes industry leaders and key partners to discuss trials and production of Ebola vaccine

WHO convened a meeting with high-ranking government representatives from Ebola-affected countries and development partners, civil society, regulatory agencies, vaccine manufacturers and funding agencies yesterday to discuss and agree on how to fast track testing and deployment of vaccines in sufficient numbers to impact the Ebola epidemic. WHO was called upon by all parties to ensure coordination...

Iproteos wins Expoquimia R&D&i Award in Biotechnology

The Catalan company was recognized in the biotechnology category

Changes to pharmaceutical policy during an economic recession

The use of antipsychotic medicines across Finland and Portugal following the recent economic recession have been analysed in order to gauge the impact of contrasting pharmaceutical policy interventions put in place over that time.

Norwegian study may be slowing adoption of biosimilar infliximab

Norway is funding clinical studies in which patients will be switched from originator biological drugs to biosimilars [1]. However, some have speculated that the NOR-SWITCH study is actually slowing the adoption of biosimilar infliximab in Norway.

FDA names and shames firms for failing to pay generics fees

No less than 28 generics makers are currently on the US Food and Drug Administration’s (FDA) GDUFA (Generic Drug User Fee Amendments) Facility Arrears List for failing to pay generics fees for 2013 and 2014.

Generics firms carve their way to victory

US generics company Mylan has won a court battle over brand-name drugmaker Hospira, meaning it is now free to resume distribution of generic Precedex (dexmedetomidine injection).

India drops planned price caps on non-essential drugs

The Indian Government has scrapped plans to extend price cuts on both generic and brand-name drugs to include ‘non-essential’ drugs.

Generics save US 1.5 trillion over last 10 years

Generics have saved consumers and the US healthcare system US$239 billion in 2013 and have saved the US nearly US$1.5 trillion between 2004 and 2013, according to a report by the Generic Pharmaceutical Association (GPhA) [1].

Cancer drug discovery system ‘broken’

The global system for discovering new cancer drugs is ‘broken’ and failing to turn scientific advances into enough innovative new medicines. This is according to Professor Paul Workman, the interim chief executive of The Institute of Cancer Research in London. Speaking at the World Oncology Forum hosted today, Workman said that big leaps forward in cancer treatment are now possible – but onl...

Photochemistry Potential Revealed in Application Notes

The incredibly powerful potential of photochemistry is revealed in four application notes recently posted by Suffolk-based flow chemistry engineering firm Vapourtec. The four application notes cover 'Synthesis of Artemisinin using E-Seriesand UV-150 reactor' (Application Note 39), 'α-Photodecarboxylation of Phthaloyl Glycine' (38), 'Photochemical Transformation of Methyl Coumalate' (37) and ...

Lacklustre sales hit Lilly again

Lilly is enduring one of the bleakest financial years in its history as patent expiries continue to take chunks out of its balance sheet. In its latest third quarter results Lilly says its sales were down an eye-watering 16% to $4.85 billion, with much of these losses down to the generic erosion of its once biggest selling drug Cymbalta (duloxetine). read more

Gas Bubblers Ensure Maintenance of Inert Reaction Atmospheres

Asynt has introduced a new range of Gas Bubblers that enable chemists to visibly confirm that their reaction system is being flushed with an inert gas such as nitrogen. A gas bubbler is a piece of laboratory glassware which consists of a glass bulb filled with a small amount of fluid such as mineral or silicone oil. For use with reactions the inlet to t...

A New Solid-State Platform for High-Throughput ChIP

Porvair Sciences, in conjunction with researchers at Swansea University (UK) have written a new technical article entitled 'Chromatrap® 96: a new solid-state platform for high-throughput Chromatin Immunoprecipitation (ChIP)' Epigenetics is a fast-growing research area with wide applications, including disease mechanism profiling and personalized medicine strategies. ChIP is crucial t...

Accinov, the Innovation Centre of Lyonbiopole, Obtains the Authorization to Open a Pharmaceutical Site from the French Health Authority (ANSM)

Lyonbiopole announces that the French Health authority (ANSM) delivered to Accinov, its Innovation Centre, the authorization to open a pharmaceutical site. This authorization will allow Accinov to support the companies hosted in the Centre for the production of biological drugs for clinical trials in particular with the pharmaceutical responsibility of Accinov. On September 11th, the French Healt...

Thursday 23rd October 2014

Mali confirms its first case of Ebola

Mali’s Ministry of Health has confirmed the country’s first case of Ebola virus disease. The Ministry received positive laboratory results, from PCR testing, on Thursday and informed WHO immediately. In line with standard procedures, samples are being sent to a WHO-approved laboratory for further testing and diagnostic work. In telephone conversation on Thursday night, health officials gave W...

October 2014 Focus Newsletter

http://www.cobioscience.com/_docs/Oct%20Focus%202014%20Final.pdf 

Improved compliance needed with NCAA concussion guidelines

For immediate release: Thursday, October 23, 2014 Boston, MA — Though most NCAA colleges and universities have created programs to help athletes deal with concussions,…


Search BioPortfolio:
Loading
Advertisement
Advertisement